Reducing Animal Testing Act
This bill removes animal studies as a required component of biosimilar applications and instead allows applicants to use other types of studies to assess toxicity.
To allow manufacturers and sponsors of a drug to use alternative 
    testing methods to animal testing to investigate the safety and 
                 effectiveness of a biological product.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Reducing Animal Testing Act''.

SEC. 2. NEW APPROACH METHODOLOGIES.

    Item (bb) of section 351(k)(2)(A)(i)(I) of the Public Health 
Service Act (42 U.S.C. 262(k)(2)(A)(i)(I)) is amended to read as 
follows:
                                            ``(bb) an assessment of 
                                        toxicity (which may rely on, or 
                                        consist of, a study or studies 
                                        described in item (aa) or 
                                        (cc)); and''.
                                 <all>
Reducing Animal Testing Act
A bill to allow manufacturers and sponsors of a drug to use alternative testing methods to animal testing to investigate the safety and effectiveness of a biological product.
Reducing Animal Testing Act
Sen. Lujan, Ben Ray